Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rVIII-SingleChain in Chinese PTPs With Hemophilia A
NCT06738485Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jan 2025
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lonoctocog alfa in hemophilia A, sponsored by CSL Limited. Started Jan 2025; status: completed.
02
Drugs
lonoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT06738485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06738485.